{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:44:41Z","timestamp":1785818681961,"version":"3.56.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Nonfermenting Gram-negative bacilli other than\n                      <jats:italic toggle=\"yes\">Pseudomonas<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Acinetobacter<\/jats:italic>\n                      species are increasingly recognized as opportunistic pathogens in pediatric populations, yet their epidemiology and antimicrobial resistance remain poorly defined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a multicenter retrospective analysis across 56 hospital centers in 25 European countries, including pediatric blood culture isolates collected between January 2020 and December 2024. Species distribution and antimicrobial susceptibility profiles according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) current guidelines were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 382 isolates were included, spanning 19 genera and 40 species.\n                      <jats:italic toggle=\"yes\">Stenotrophomonas maltophilia<\/jats:italic>\n                      was the most frequently identified species (46.9%; n = 179), followed by\n                      <jats:italic toggle=\"yes\">Roseomonas mucosa<\/jats:italic>\n                      (10%; n = 38) and\n                      <jats:italic toggle=\"yes\">Sphingomonas paucimobilis<\/jats:italic>\n                      (7.6%; n = 29). Susceptibility profiles were heterogeneous, with notable resistance across several species. For\n                      <jats:italic toggle=\"yes\">S. maltophilia<\/jats:italic>\n                      , resistance to trimethoprim\/sulfamethoxazole exceeded 10% (EUCAST), while full in vitro susceptibility to aztreonam\/avibactam was observed. Preserved activity of carbapenems but high resistance to ceftazidime (EUCAST\/CLSI), piperacillin\/tazobactam (EUCAST\/CLSI) and ciprofloxacin (CLSI) was observed for\n                      <jats:italic toggle=\"yes\">S. paucimobilis<\/jats:italic>\n                      .\n                      <jats:italic toggle=\"yes\">Achromobacter<\/jats:italic>\n                      several species showed concerning resistance patterns to carbapenems, piperacillin\/tazobactam and trimethoprim\/sulfamethoxazole (CLSI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Nonfermenting Gram-negative bacilli other than\n                      <jats:italic toggle=\"yes\">Pseudomonas<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Acinetobacter<\/jats:italic>\n                      species were frequently associated with healthcare exposure and complex resistance profiles. Their management is challenged by a lack of evidence and standardized susceptibility criteria. To optimize management, enhanced surveillance, improved diagnostic standardization and further clinical studies on emerging therapies are needed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005351","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:00:33Z","timestamp":1785816033000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Nonfermenting Gram-Negative Bacilli Other Than Pseudomonas and Acinetobacter Species in Pediatric Blood Cultures: A Multicenter European Analysis"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-5075","authenticated-orcid":false,"given":"Gabriele","family":"Bianco","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, University of Salento, Lecce, Italy"},{"name":"Microbiology and Virology Unit, Vito Fazzi Hospital, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6519-0593","authenticated-orcid":false,"given":"Anezka","family":"Gryndlerova","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Second Faculty of Medicine, Charles University and Motol and Homolka University Hospital, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Sch\u00f8nning","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Copenhagen University Hospital\u2013Rigshospitalet, Copenhagen, Denmark"},{"name":"Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"van Kleef - van Koeveringe","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, University Hospital Antwerp, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Corvec","sequence":"additional","affiliation":[{"name":"Institut de Biologie des H\u00f4pitaux de Nantes, Service de Bact\u00e9riologie et des Contr\u00f4les Microbiologiques, CHU de Nantes, Nantes Cedex 01, France"},{"name":"INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes Universit\u00e9, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-5518","authenticated-orcid":false,"given":"Coralie","family":"Bouchiat","sequence":"additional","affiliation":[{"name":"Laboratoire de Bact\u00e9riologie, Institut des Agents Infectieux, Hospice Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jean-Pierre","sequence":"additional","affiliation":[{"name":"HydroSciences Montpellier, University of Montpellier, CNRS, IRD, Service de Microbiologie et Hygi\u00e8ne Hospitali\u00e8re, CHU de N\u00eemes, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betig\u00fcl","family":"\u00d6ngen","sequence":"additional","affiliation":[{"name":"\u0130stanbul Faculty of Medicine, Department of Medical Microbiology, \u0130stanbul University, \u0130stanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Cant\u00f3n","sequence":"additional","affiliation":[{"name":"Servicio de Microbiolog\u00eda, Hospital Universitario Ram\u00f3n y Cajal and Instituto Ram\u00f3n y Cajal de Investigaciones Sanitarias, Madrid, Spain"},{"name":"CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-2716","authenticated-orcid":false,"given":"Matteo","family":"Boattini","sequence":"additional","affiliation":[{"name":"Microbiology and Virology Unit, University Hospital Citt\u00e0 della Salute e della Scienza di Torino, Turin, Italy"},{"name":"Department of Public Health and Paediatrics, University of Torino, Turin, Italy"},{"name":"Lisbon Academic Medical Centre, Lisbon, Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the MINOFEu Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"R1-20260804","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/JCM.03264-15","article-title":"Carbapenem-resistant non-glucose-fermenting gram-negative bacilli: the missing piece to the puzzle.","volume":"54","author":"Gniadek","year":"2016","journal-title":"J Clin Microbiol"},{"key":"R3-20260804","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/phar.2447","article-title":"An overview of the treatment of less common non-lactose-fermenting gram-negative bacteria.","volume":"40","author":"Spencer","year":"2020","journal-title":"Pharmacotherapy"},{"key":"R4-20260804","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/QCO.0000000000000977","article-title":"Current viewpoint on the epidemiology of nonfermenting Gram-negative bacterial strains.","volume":"36","author":"Koulenti","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"R5-20260804","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/0974-777X.121996","article-title":"Nonfermenting gram-negative acilli other than Pseudomonas aeruginosa and Acinetobacter spp. causing respiratory tract infections in a tertiary care center.","volume":"5","author":"Chawla","year":"2013","journal-title":"J Glob Infect Dis"},{"key":"R6-20260804","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2334-13-167","article-title":"Epidemiology of bacteremia caused by uncommon non-fermentative gram-negative bacteria.","volume":"13","author":"Rattanaumpawan","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R7-20260804","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7883\/yoken.66.507","article-title":"Emergence of unusual nonfermenting gram-negative nosocomial pathogens in a Saudi hospital.","volume":"66","author":"Asaad","year":"2013","journal-title":"Jpn J Infect Dis"},{"key":"R8-20260804","first-page":"306","article-title":"Rare or unusual non-fermenting gram-negative bacteria: therapeutic approach and antibiotic treatment options. antibiotics.","volume":"14","author":"Geremia","year":"2025","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"R9-20260804","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1097\/TP.0000000000000709","article-title":"Pan-resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia infection in cystic fibrosis does not reduce survival after lung transplantation.","volume":"99","author":"Lobo","year":"2015","journal-title":"Transplantation"},{"key":"R10-20260804","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijantimicag.2018.09.001","article-title":"Antimicrobial susceptibility of non-fermenting gram-negative pathogens isolated from cystic fibrosis patients.","volume":"53","author":"D\u00edez-Aguilar","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"R11-20260804","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/INF.0000000000004530","article-title":"Stenotrophomonas maltophilia associated factors and outcomes in a neonatal intensive care unit: a retrospective matched case-control study.","volume":"44","author":"Franco","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20260804","doi-asserted-by":"crossref","first-page":"e0367425","DOI":"10.1128\/spectrum.03674-25","article-title":"Achromobacter infections from a pediatric population in Qatar.","volume":"14","author":"Suleiman","year":"2026","journal-title":"Microbiol Spectr"},{"key":"R13-20260804","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhin.2014.07.012","article-title":"Achromobacter bacteraemia outbreak in a paediatric onco-haematology department related to strain with high surviving ability in contaminated disinfectant atomizers.","volume":"89","author":"Hugon","year":"2015","journal-title":"J Hosp Infect"},{"key":"R14-20260804","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12879-026-12577-3","article-title":"Experience of an environmental-associated Stenotrophomonas maltophilia colonization outbreak: genetic diversity and outbreak management.","volume":"26","author":"Atici","year":"2026","journal-title":"BMC Infect Dis"},{"key":"R15-20260804","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhin.2021.02.001","article-title":"Investigation and control of an outbreak due to a contaminated hospital water system, identified following a rare case of Cupriavidus pauculus bacteraemia.","volume":"111","author":"Inkster","year":"2021","journal-title":"J Hosp Infect"},{"key":"R16-20260804","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhin.2018.03.025","article-title":"Septic shock due to meropenem- and colistin-resistant Cupriavidus pauculus.","volume":"99","author":"Bianco","year":"2018","journal-title":"J Hosp Infect"},{"key":"R17-20260804","first-page":"374","article-title":"Ralstonia mannitolilytica bacteraemia: a case report and literature review.","volume":"26","author":"Boattini","year":"2018","journal-title":"Infez Med"},{"key":"R18-20260804","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections.","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R19-20260804","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12941-024-00709-z","article-title":"Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains.","volume":"23","author":"Jean-Pierre","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R20-20260804","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jpids\/piz002","article-title":"Defining the role of novel \u03b2-lactam agents that target carbapenem-resistant gram-negative organisms.","volume":"8","author":"Tamma","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R21-20260804","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/INF.0000000000005134","article-title":"Real-world use of cefiderocol in neonatal and pediatric populations: a multicenter case series and systematic review.","volume":"45","author":"Mantsiou","year":"2026","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20260804","doi-asserted-by":"crossref","first-page":"107772","DOI":"10.1016\/j.ijantimicag.2026.107772","article-title":"Minor non-fermenting Gram-negative bacilli in Europe, 2020-2024 (MINOFEu).","volume":"67","author":"Bianco","year":"2026","journal-title":"Int J Antimicrob Agents"},{"key":"R26-20260804","doi-asserted-by":"crossref","first-page":"e0026425","DOI":"10.1128\/jcm.00264-25","article-title":"Defining antimicrobial susceptibility testing methods and breakpoints among Achromobacter species.","volume":"63","author":"Harris","year":"2025","journal-title":"J Clin Microbiol"},{"key":"R27-20260804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America.","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R28-20260804","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/10766294251359795","article-title":"Genetic diversity of Stenotrophomonas spp. and its impact on diagnosis and treatment of pediatric infections.","volume":"31","author":"Rodrigues","year":"2025","journal-title":"Microb Drug Resist"},{"key":"R29-20260804","doi-asserted-by":"crossref","first-page":"752037","DOI":"10.3389\/fonc.2021.752037","article-title":"Stenotrophomonas maltophilia infections in pediatric patients - experience at a European Center for Pediatric Hematology and Oncology.","volume":"11","author":"Z\u00f6llner","year":"2021","journal-title":"Front Oncol"},{"key":"R30-20260804","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13756-021-00888-w","article-title":"Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.","volume":"10","author":"Alsuhaibani","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"R31-20260804","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1097\/MPH.0b013e318290d503","article-title":"Bacteremia due to imipenem-resistant Roseomonas mucosa in a child with acute lymphoblastic leukemia.","volume":"36","author":"Michon","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"R32-20260804","doi-asserted-by":"crossref","first-page":"000213","DOI":"10.1099\/acmi.0.000213","article-title":"Meningitis due to Roseomonas in an immunocompetent adolescent.","volume":"3","author":"Waris","year":"2021","journal-title":"Access Microbiol"},{"key":"R33-20260804","doi-asserted-by":"crossref","first-page":"374","DOI":"10.7883\/yoken.JJID.2021.661","article-title":"Sphingomonas paucimobilis outbreak a pediatric hematology-oncology hospital: epidemiological investigation and literature review of an emerging healthcare-associated infection.","volume":"75","author":"A\u015fkin","year":"2022","journal-title":"Jpn J Infect Dis"},{"key":"R34-20260804","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1097\/INF.0000000000003301","article-title":"The first report of sphingomonas yanoikuyae as a human pathogen in a child with a central nervous system infection.","volume":"40","author":"Guner Ozenen","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R35-20260804","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cmi.2016.05.024","article-title":"Skin microbiota is the main reservoir of Roseomonas mucosa, an emerging opportunistic pathogen so far assumed to be environmental.","volume":"22","author":"Romano-Bertrand","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R36-20260804","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.14202\/vetworld.2025.4196-4211","article-title":"Comprehensive identification of contagious, environmental, and emerging microorganisms associated with bovine mastitis in Northern Minas Gerais, Brazil, using MALDI-TOF mass spectrometry.","volume":"18","author":"Santos","year":"2025","journal-title":"Vet World"},{"key":"R37-20260804","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1097\/INF.0000000000002800","article-title":"Risk factors of Stenotrophomonas maltophilia blood stream infections: comparison with other gram-negative blood stream infections in children.","volume":"39","author":"Gayretli Ayd\u03b9n","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"R38-20260804","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41390-021-01878-9","article-title":"Antibiotics in critically ill children-a narrative review on different aspects of a rational approach.","volume":"91","author":"Bruns","year":"2022","journal-title":"Pediatr Res"},{"key":"R39-20260804","doi-asserted-by":"crossref","first-page":"e27363","DOI":"10.1002\/ppul.27363","article-title":"Successful treatment of Stenotrophomonas maltophilia with ceftazidime-avibactam and aztreonam in an individual with cystic fibrosis: a case report.","volume":"60","author":"Duehlmeyer","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"R40-20260804","doi-asserted-by":"crossref","first-page":"e0072425","DOI":"10.1128\/jcm.00724-25","article-title":"Clinical and microbiologic features of Achromobacter species: a 10-year, multicenter experience.","volume":"63","author":"Bayless","year":"2025","journal-title":"J Clin Microbiol"},{"key":"R41-20260804","doi-asserted-by":"crossref","first-page":"e01025","DOI":"10.1128\/AAC.01025-20","article-title":"Achromobacter infections and treatment options.","volume":"64","author":"Isler","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R42-20260804","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cmi.2023.08.029","article-title":"Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis.","volume":"30","author":"Karakonstantis","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"R43-20260804","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac492.1341","article-title":"In vitro activity of cefiderocol against US Achromobacter spp. and Burkholderia spp. Clinical isolates from the SENTRY surveillance program 2020-2021.","volume":"9","author":"Takemura","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R44-20260804","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10096-024-04745-7","article-title":"Performance evaluation of Bruker UMIC\u00ae microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species.","volume":"43","author":"Bianco","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R45-20260804","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/antibiotics12030604","article-title":"Disc diffusion and ComASP\u00ae cefiderocol microdilution panel to overcome the challenge of cefiderocol susceptibility testing in clinical laboratory routine.","volume":"12","author":"Bianco","year":"2023","journal-title":"Antibiotics"},{"key":"R46-20260804","doi-asserted-by":"crossref","first-page":"e2013040","DOI":"10.4084\/mjhid.2013.040","article-title":"Sphingomonas paucimobilis infections in children: 24 case reports.","volume":"5","author":"Bayram","year":"2013","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R47-20260804","doi-asserted-by":"crossref","first-page":"e20241944","DOI":"10.1590\/1806-9282.20241944","article-title":"A retrospective study: management of Rhizobium radiobacter-associated bloodstream infections in pediatric hematology and oncology patients.","volume":"71","author":"Tekeli","year":"2025","journal-title":"Rev Assoc Med Bras (1992)"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:00:40Z","timestamp":1785816040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":43,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005351","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}